Patent · US Active

Therapeutic compositions

US8372828B2 · kind B2 · utility

8Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2012
Grant dateFeb 12, 2013
Priority date—
Expiry dateJul 31, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.